Consistently, previously studies have reported that KMT5C promotes tumor progression in pancreatic cancer and clear cell renal cell carcinoma.[15, 16] Similarly, we and others have revealed that KMT5C is a tumor‐promoting protein in liver cancer.[9, 39] These findings are consistent with the current results. Here, KMT5C is linked to liver cancer.